Unhealthy Heart May Be Bigger Threat to Women's Brains Than Men's
US News & World Report - January 06, 2022
Richard Lipton, M.D., comments on a study highlighting the connection between heart and brain health, particularly in women. Dr. Lipton is professor in the Saul R. Korey Department of Neurology, of psychiatry and behavioral sciences, and of epidemiology & population health and holds the Edwin S. Lowe Professor at Einstein, and is vice chair of neurology at Einstein and Montefiore.
Furor Rages Over FDA Approval of Controversial Alzheimer's Drug
The Washington Post - June 17, 2021
Richard Lipton, M.D., says he supports the FDA's approval of a controversial new drug to treat Alzheimer's, and notes that he would have given the drug to his late mother, who suffered from the disease. Dr.Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and Montefiore.
CNN interviews Richard Lipton, M.D., about a new study that finds moderate to intense exercise may slow the rate of mental decline. Dr. Lipton notes the study shows that low physical activity predicts cognitive decline, including the abilities that are important for everyday function such as processing speed and episodic memory. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
March 29, 2016
CBS News interviews Richard Lipton, M.D., about his new research that finds stress doubles the chance of seniors developing a pre-Alzheimer’s condition. Along with Mindy Katz, M.P.H., the Einstein Aging Study team suggests that treating stress in the elderly may delay or even avoid the onset of dementia. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center. Ms. Katz is a senior associate in the Saul R. Korey Department of Neurology.
More coverage on this story
HealthDay
UPI
The Sun (UK)
The Times of India
Huffington Post
Voice of America
Medscape
Daily Mail (UK)
US News & World Report (via Healthday)
December 14, 2015
The Washington Post interviews Richard Lipton, M.D., about Einstein Aging Study (EAS) research presented at the 2015 Alzheimer’s Association conference. Among the eleven EAS oral and poster presentations, Dr. Lipton discusses two: one that indicates the incidence of dementia is declining and another that suggests psychological stress can elevate the risk of developing dementia. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
July 20, 2015
NBC News interviews Richard Lipton, M.D., about a new class of drugs designed to prevent the onset of migraine. Dr. Lipton comments that these new medications have been shown to be remarkably effective and come with few side effects, based on a Phase II trial. Dr. Lipton is director of the Montefiore Headache Center, vice chair of Neurology at Einstein and Montefiore and holds the Edwin S. Lowe Chair in Neurology at Einstein.
June 18, 2015
The Washington Post interviews Richard Lipton, M.D., on the warning signs of dementia. Dr. Lipton notes that when it comes to memory lapses, retrieval problems are of less concern than storage problems. For example, forgetting the name of someone you just met is normal, but forgetting the person entirely may be a warning sign of something more serious. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
April 6, 2015
The Washington Post interviews Richard Lipton, M.D., about a promising multi-drug approach to treating Alzheimer’s diseases. Dr. Lipton notes that combining therapies, rather than relying on a single drug, tends to be more effective, but cautions that this new treatment has yet to be tested in humans. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
January 12, 2015
The Washington Post interviews Richard Lipton, M.D., about why more women than men develop Alzheimer’s disease. Research from Dr. Lipton’s Einstein Aging Study found that women, ages 70 to 79, were more than twice as likely to develop Alzheimer’s or other forms of dementia as men of the same age, but that after the age of 80 the risk is similar for both genders. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
September 4, 2014
The New York Times interviews Richard Lipton, M.D., about research from the Einstein Aging Study (EAS) which found an association between perceived stress and dementia. As part of two separate EAS studies, participants were surveyed about perceived stress. For healthy participants, cognitive loss was associated with scoring highest for stress and anxiety over a four-year period while the risk of dementia was two-and-a-half times greater for participants who had amnestic mild cognitive impairment and the highest perceived stress. Dr. Lipton is director of the Einstein Aging Study and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the division of cognitive aging and dementia at Montefiore Medical Center.
July 16, 2014
Bloomberg features new research by Richard Lipton, M.D., and Mindy Katz, M.P.H., finding early memory loss doubles the risk of dying. Ms. Katz notes the importance of detecting early Alzheimer’s symptoms since it may help reduce the risks of illness that lead to premature death. Dr. Lipton is professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and Montefiore Medical Center and director of the Einstein Aging Study. Ms. Katz is senior associate in the Saul R. Korey Department of Neurology at Einstein and Montefiore.
More coverage on this story
Los Angeles Times
USA Today
U.S. News & World Report
July 17, 2012
U.S. News & World Report (via HealthDay) interviews Richard Lipton, M.D., on a new study linking migraine to depression in women. Dr. Lipton notes the large number of participants and the length of time they were followed make the findings important, but identifies some drawbacks of the study, including that it didn’t include women under 45 and that the depression was self-reported. Dr. Lipton is vice chair of neurology at Einstein and director of Montefiore’s Headache Center.
February 23, 2012